Literature DB >> 19572319

In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells.

Stefano Vavassori1, Yufang Shi, Chiann-Chyi Chen, Yacov Ron, Lori R Covey.   

Abstract

Interactions between CD40 and its ligand CD154 are involved in the progression of both cell mediated and innate immunity. These interactions are brought about by the transient expression of CD154 on activated CD4(+) T cells, which is regulated, in part, at the level of mRNA turnover. Here we have focused on analyzing the pattern of post-transcriptional regulation in mouse CD4(+) T cells in response to activation. Initial experiments identify a region of the murine CD154 mRNA that binds a polypyrimidine tract-binding protein-containing complex (mComplex I), which is activation-dependent and binds to a single CU-rich site within the 3' uTR Subsequent findings demonstrate that in vivo polyclonal activation of T cells leads to a pattern of differential CD154 mRNA stability that is directly dependent on extent of activation. Furthermore, in vitro activation of antigen-primed T cells shows that the CD154 mRNA half-life increases relative to that of unprimed cells. Importantly, this is the first report demonstrating that the regulation of CD154 in vivo is connected to an activation-induced program of mRNA decay and thus provides strong evidence for post-transcriptional mechanisms having a physiological role in regulating CD154 expression during an ongoing immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572319      PMCID: PMC2856466          DOI: 10.1002/eji.200839163

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation.

Authors:  G S Ford; B Barnhart; S Shone; L R Covey
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

2.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

3.  Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA.

Authors:  K Murakami; W Ma; R Fuleihan; J S Pober
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

Review 4.  CD40 and CD154 in cell-mediated immunity.

Authors:  I S Grewal; R A Flavell
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

5.  IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.

Authors:  X Peng; J E Remacle; A Kasran; D Huylebroeck; J L Ceuppens
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

6.  Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mechanisms.

Authors:  A Suárez; L Mozo; A Gayo; J Zamorano; C Gutierrez
Journal:  Eur J Immunol       Date:  1997-11       Impact factor: 5.532

7.  Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice.

Authors:  C H Clegg; J T Rulffes; H S Haugen; I H Hoggatt; A Aruffo; S K Durham; A G Farr; D Hollenbaugh
Journal:  Int Immunol       Date:  1997-08       Impact factor: 4.823

8.  Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival.

Authors:  D Yin; L Zhang; R Wang; L Radvanyi; C Haudenschild; Q Fang; M R Kehry; Y Shi
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

9.  Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphocytes.

Authors:  W F Rigby; M G Waugh; B J Hamilton
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

10.  Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.

Authors:  C Johnson-Léger; J R Christenson; M Holman; G G Klaus
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

View more
  9 in total

Review 1.  Post-transcriptional regulons coordinate the initiation and resolution of inflammation.

Authors:  Paul Anderson
Journal:  Nat Rev Immunol       Date:  2010-01       Impact factor: 53.106

2.  Polypyrimidine tract-binding protein is critical for the turnover and subcellular distribution of CD40 ligand mRNA in CD4+ T cells.

Authors:  Rodrigo Matus-Nicodemos; Stefano Vavassori; Moraima Castro-Faix; Anibal Valentin-Acevedo; Karnail Singh; Valentina Marcelli; Lori R Covey
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

3.  Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-01       Impact factor: 4.147

4.  Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4+ 8- thymocytes and invariant NKT cells but not in Treg cells.

Authors:  Yoshinobu Koguchi; Abigail C Buenafe; Timothy J Thauland; Jennifer L Gardell; Elizabeth R Bivins-Smith; David B Jacoby; Mark K Slifka; David C Parker
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

5.  A Posttranscriptional Pathway of CD40 Ligand mRNA Stability Is Required for the Development of an Optimal Humoral Immune Response.

Authors:  Bitha Narayanan; Diego Prado de Maio; James La Porta; Yekaterina Voskoboynik; Usha Ganapathi; Ping Xie; Lori R Covey
Journal:  J Immunol       Date:  2021-05-24       Impact factor: 5.426

6.  The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers.

Authors:  Elisa Monzón-Casanova; Michael Screen; Manuel D Díaz-Muñoz; Richard M R Coulson; Sarah E Bell; Greta Lamers; Michele Solimena; Christopher W J Smith; Martin Turner
Journal:  Nat Immunol       Date:  2018-01-22       Impact factor: 25.606

7.  RNA-binding protein Ptbp1 is essential for BCR-mediated antibody production.

Authors:  Hiroki Sasanuma; Manabu Ozawa; Nobuaki Yoshida
Journal:  Int Immunol       Date:  2019-03-05       Impact factor: 4.823

8.  Polypyrimidine tract binding protein 1 regulates the activation of mouse CD8 T cells.

Authors:  Vanessa D'Angeli; Elisa Monzón-Casanova; Louise S Matheson; Özge Gizlenci; Georg Petkau; Clare Gooding; Rebecca V Berrens; Christopher W J Smith; Martin Turner
Journal:  Eur J Immunol       Date:  2022-04-29       Impact factor: 6.688

9.  Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice.

Authors:  Valentina Di Caro; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.